PharVision Advisers’s Genuine Parts GPC Stock Holding History

PharVision Advisers’s Portfolio GPC Stock Details GPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,822	Closed	-$347K	–	331
2025 Q4	$347K	Buy	+2,822	New	+$365K	0.18%	200

Other funds holding GPC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PharVision Advisers's GPC Position: Q1 2026 in Review

PharVision Advisers sold out of Genuine Parts (GPC) in Q1 2026, closing a stake of 2,822 shares — an estimated $347K sold.

PharVision Advisers first reported a position in GPC in Q4 2025 and held it in 1 quarter. The position peaked at $347K in Q4 2025. 1,075 funds tracked by Wall St. Rank hold GPC as of Q1 2026.

PharVision Advisers reported no remaining Genuine Parts position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 2,822 Genuine Parts shares in Q1 2026, an estimated $347K.
PharVision Advisers first reported a position in Genuine Parts in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Genuine Parts position peaked at $347K in Q4 2025.
1,075 funds tracked by Wall St. Rank held Genuine Parts as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.